Crispr Therapeutics shares owned by Logos Global Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Logos Global Management
from 13F filings
Historical chart of Logos Global Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Logos Global Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $16M | 300k | 54.54 |
| 2020-03-31 | $4.5M | 106k | 42.41 |